[Diagnosis and treatment of recurrent epithelial ovarian carcinoma].
OBJECTIVE
To investigate the diagnosis, treatment and prognosis of recurrent epithelial ovarian carcinoma.


METHODS
Fifty-two patients with recurrent epithelial ovarian carcinoma who were admitted in Zhongnan Hospital of Wuhan University between 1997 and 2002 were analyzed retrospectively, and their diagnostic methods and the survival rates were compared.


RESULTS
The positive diagnostic rate of pelvic examination, CA(125) and ultrasound examination was 73.1%, 84.6% and 53.8%, respectively to the recurrent epithelial ovarian carcinoma. The median survival time of group A (surgery + chemotherapy) and group B (chemotherapy) was 11 and 12 months, respectively.


CONCLUSIONS
The diagnostic methods should include pelvic examination, CA(125) and ultrasound examination. We could not know the exact role of surgery to the management and prognosis of recurrent epithelial ovarian carcinoma. Chemotherapy may have an important role to the management and prognosis of recurrent epithelial ovarian carcinoma.
Wu
Xu-feng
XF
Department of Gynecologic Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.
Chen
Hui-zhen
HZ
Han
Ding-fen
DF
D000328:Adult; D018394:CA-125 Antigen / Q000097:blood; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000628:therapy; D009375:Neoplasms, Glandular and Epithelial / Q000175:diagnosis* / Q000628:therapy; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000628:therapy; D014057:Tomography, X-Ray Computed
D018394:CA-125 Antigen